v3.24.1.1.u2
Interim Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Current assets    
Cash and cash equivalents $ 408 $ 767
Accounts receivable 55 81
Total current assets 463 848
Non- current assets    
Long term restricted deposit 11 11
Right of use assets 58 84
Property and equipment, net 47 56
Total non-current assets 116 151
Total assets 579 999
Current liabilities    
Trade and other payables 505 473
Non-current liabilities    
Stockholders’ loans 160 161
Total liabilities 665 634
Stockholders’ equity (deficiency)    
Common Stock, par value $0.001 per share, 250,000,000, shares authorized. As of March 31, 2024, and December 31, 2023, 69,931,056 shares were issued. 69 69
Additional paid-in capital 15,341 15,135
Accumulated deficit (15,496) (14,839)
Total Stockholders’ equity (deficiency) (86) 365
Total liabilities and stockholders’ equity (deficiency) $ 579 $ 999

Source